Myocardial Protection: Role of Vasoactive Drugs
- 1 September 1988
- journal article
- Published by Elsevier in Anesthesiology Clinics of North America
- Vol. 6 (3) , 569-591
- https://doi.org/10.1016/s0889-8537(21)00265-0
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Failure of high doses of propranolol to reduce experimental myocardial ischemic damage.Circulation, 1978
- Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction.Circulation, 1976
- Regional contractility. Selective depression of ischemic myocardium by verapamil.Circulation, 1976
- Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.Circulation, 1976
- Regional Myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine.Circulation, 1976
- Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;.Circulation, 1975
- Intravenous nitroglycerin in acute myocardial infarction.Circulation, 1975
- Propranolol in the Treatment of Acute Myocardial InfarctionCirculation, 1974
- Factors Influencing Infarct Size Following Experimental Coronary Artery OcclusionsCirculation, 1971